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Berridge makes a good case for each phase,
deftly arraying evidence in point. Throughout
she makes good use ofthe research and
analysis ofother scholars, crediting them
thoroughly in both text and notes.
Many readers will disagree with particular
emphases and interpretations. This reviewer
remains sceptical about the extent to which
policy (as opposed to political talk) was
influenced by interest groups ofgays in the
mid-1980s. I was also surprised to read (pages
4-5 and 183) that I had promoted a chronic
disease model ofHIV/AIDS that was useful to
some political groups and that I had endorsed a
different model several years earlier. In both
instances I was observing, not preaching; a
crime reporter, as it were, rather than a
criminal. Moreover, during the first few years
that my colleagues and I argued that policy for
AIDS was increasingly resembling policy for
chronic disease management, we were more
often attacked than applauded in both the UK
and the U.S.
Hannaway and her colleagues commissioned
fifteen papers. Nine ofthem are informative
and engaging autobiographical accounts by
distinguished participants in policy making,
research, clinical medicine, andjournalism
(some in several ofthese roles) during the
epidemic. Particularly insightful and moving
are the essays by C Everett Koop, former U.S.
Surgeon General, James Curran, an official of
the Centers for Disease Control and
Prevention, Anthony Fauci, director ofthe
National Institute ofAllergy and Infectious
Disease, and Mark Smith, an internist who is
now President ofthe California Health Care
Foundation.
Most ofthe other papers, by professional
historians and a physician-anthropologist, are
informative. Noteworthy are Victoria Harden's
review ofthe response ofthe National
Institutes ofHealth to the epidemic, Anne
Marie Moulin's study ofblood transfusion and
the transmission ofAIDS in France and
Maryinez Lyons' paper on AIDS among
women in Uganda.
Berridge makes an analogy between British
mobilization for World War II and AIDS policy
in the late 1980s in both her book and her
paper in the volume edited by Hannaway etal.
Historians had a good war both times.
Daniel M Fox, Milbank Memorial Fund
Stephen RKandali, with the assistance of
Jennifer Petrillo, Substance and shadow:
women andaddiction in the UnitedStates,
Cambridge, Mass., and London, Harvard
University Press, 1996, pp. xiii, 353, illus.,
£19.95 (hardback 0-674-85360-1).
In July 1989, Stephen R Kandall, the author
ofthis book, found himselfin a Central Florida
courtroom testifying on behalfofJennifer
Johnson. Johnson, a young African American
woman, had been charged with delivery ofa
controlled substance (cocaine) to a minor. The
prosecution alleged that the delivery had been
made in the short time between the birth ofher
baby and the clamping ofthe umbilical cord.
Johnson was convicted, but, in 1992, the
judgement was overturned by the Florida
Supreme Court. "The Court declines the State's
invitation to walk down a path that the law,
public policy, and common sense forbid it to
tread."
Kandall, with long experience through the
Beth Israel medical centre in New York in
caring fordrug-exposed babies and with
extensive publications on the effects ofmaternal
drug use in pregnancy, realized that he knew
little ofthe history ofwomens' involvement in
drug use, and consequent stigmatization. This
book is the result. Exclusively American
focused, it traces the involvement ofwomen
with drugs since the nineteenth century and the
ways in which the issue has been publicly
presented. Women, he argues, have always
formed a large proportion ofthose who use
drugs, but only at certain stages has their use
emerged as a matter ofconcern. The easy
availability ofopiates in the nineteenth century,
physician prescription, opiate-based patent
medicines, the use ofwomen oriented diagnoses
such as neurasthenia, created a widespread
female user clientele.
515Book Reviews
As U.S. drug control policy hardened to a
prohibitionist stance in the wake of
international control legislation and the 1914
Harrison Narcotics Act, the female drug user
remained a barely visible part ofthe drug
scene. The hard line on drugs extended into the
1950s; it was only after the modification of
national policy towards drug use during the
1960s, with an acceptance ofthe disease view
ofaddiction and the consequent rise of
methadone maintenance, that women started to
emerge in their own right. In perhaps the most
original part ofthe book, Kandall traces the
emergence ofwomen focused research and
other programmes after the establishment of
the National Institute ofDrug Abuse in 1974.
NIDA's use ofepidemiological national
surveys made the role ofwomen in drug use
clearer; and the womens' movement also took
this up as an issue. But the Reagan
administration saw a harsher line imposed.
Concern about drug use in pregnancy was
revived, fuelled by the role ofdrug use in the
transmission ofHIV/AIDS, and leading to
cases such as the Johnson one.
This is an interesting book, packed with
historical "fact". Kandall and his research
assistant have worked hard, as he
acknowledges. I would have preferred a little
more standing back from the material. It would
have been useful to have some general themes
outlined and contextualized. How problems
emerge and who defines them are not part of
the book's agenda. Women and drug use have
emerged both as a "risk group" for policy
makers and as a variously defined feminist
issue since the 1970s. Both epidemiology and
psychology have been involved as explanatory
frameworks. The focus on women as mothers
mirrors the turn ofthe century concern for
womens' role in the "future ofthe race". The
tension between the objective ongoing
"realities" and dimensions offemale drug use
and its policy and public definition is not
explicitly addressed. Kandall's final chapter,
which might have pulled together some of
these themes, is directly focused on possible
modifications in current U.S. policy. But in
general this is a valuable first step in analysis
of an important historical and contemporary
dimension ofdrug use.
Virginia Berridge,
London School ofHygiene and
Tropical Medicine
B G Firkin and J A Whitworth, Dictionary
ofmedical eponyms, New York and London,
Parthenon Publishing, 1996, pp. viii, 443,
illus., £35.00, $59.00 (1-85070-477-5).
This dictionary presents some 2,185
personal names, biographies and descriptions
ofthe diseases and similar medical items
which go by these names. It is clearly a labour
oflove, and includes unexpected and
surprising information, such as the cause of
Guillotin's death. It is, however, not the only
source ofits kind, and intending users should
note how it defines its field and whether it
promises what they seek.
Its Introductions supply the field: "eponyms
used in the practice of internal medicine [my
italics] in Australia and probably in most ofthe
English-speaking countries in the world". The
unwary reader ofthe title Dictionary of
medical eponyms might expect that people
would be included after whom any item in
medicine had been named: medicine to include
surgery, midwifery, and sciences closely
associated with medicine, and the items to
include syndromes, diseases, tumours, surgical
instruments, drugs, tests, organisms, units,
reactions, and so forth. The present book's
field is much narrower, although it extends
beyond real people; a few fictitious people are
included, such as Job and Ondine and
Pickwick, and so are some places, such as
Bornholm, Oroya, and the Rocky Mountains.
Some items, for instance the Gigli saw and the
Smith-Petersen nail, are in Australia apparently
within the adventurous scope ofinternal
medicine, yet might be regarded elsewhere as
beyond it. But nothing is offered here about,
for example, Ramstedt, Syme, Spencer Wells,
Mayo, Gamgee, Esmarch, and such idols of
surgery.
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